However, we already observed a clear trend towards a better therapy response rate regarding the ALP-level ≤ 1.67 × ULN and bilirubin normalization and a significant reduction of gGT after the addition of obeticholic acid to UDCA.
← all excerpts
Real-World Clinical Management of Patients with Primary Biliary Cholangitis-A Retrospective Multicenter Study from Germany.
1
—
—